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Abstract
Data-driven Machine Learning has emerged as a promis-
ing approach for building accurate and robust statisti-
cal models from medical data, which is collected in huge
volumes by modern healthcare systems. Existing medi-
cal data is not fully exploited by ML primarily because it
sits in data silos and privacy concerns restrict access to
this data. However, without access to sufficient data, ML
will be prevented from reaching its full potential and, ulti-
mately, from making the transition from research to clin-
ical practice. This paper considers key factors contribut-
ing to this issue, explores how Federated Learning (FL)
may provide a solution for the future of digital health and
highlights the challenges and considerations that need to
be addressed.
∗Disclaimer: The opinions expressed herein are those of the authors
and do not necessarily represent those of the institutions they are affil-
iated with, e.g. the U.S. Department of Health and Human Services or
the National Institutes of Health.
1 Introduction
Research on artificial intelligence (AI) has enabled a va-
riety of significant breakthroughs over the course of the
last two decades. In digital healthcare, the introduction of
powerful Machine Learning-based and particularly Deep
Learning-based models [1] has led to disruptive innova-
tions in radiology, pathology, genomics and many other
fields. In order to capture the complexity of these ap-
plications, modern Deep Learning (DL) models feature a
large number (e.g. millions) of parameters that are learned
from and validated on medical datasets. Sufficiently large
corpora of curated data are thus required in order to ob-
tain models that yield clinical-grade accuracy, whilst be-
ing safe, fair, equitable and generalising well to unseen
data [2, 3, 4].
For example, training an automatic tumour detector and
diagnostic tool in a supervised way requires a large anno-
tated database that encompasses the full spectrum of pos-
sible anatomies, pathological patterns and types of input
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data. Data like this is hard to obtain and curate. One of
the main difficulties is that unlike other data, which may
be shared and copied rather freely, health data is highly
sensitive, subject to regulation and cannot be used for re-
search without appropriate patient consent and ethical ap-
proval [5]. Even if data anonymisation is sometimes pro-
posed as a way to bypass these limitations, it is now well-
understood that removing metadata such as patient name
or date of birth is often not enough to preserve privacy [6].
Imaging data suffers from the same issue - it is possible to
reconstruct a patient’s face from three-dimensional imag-
ing data, such as computed tomography (CT) or magnetic
resonance imaging (MRI). Also the human brain itself has
been shown to be as unique as a fingerprint [7], where
subject identity, age and gender can be predicted and re-
vealed [8]. Another reason why data sharing is not sys-
tematic in healthcare is that medical data are potentially
highly valuable and costly to acquire. Collecting, curating
and maintaining a quality dataset takes considerable time
and effort. These datasets may have a significant busi-
ness value and so are not given away lightly. In practice,
openly sharing medical data is often restricted by data col-
lectors themselves, who need fine-grained control over the
access to the data they have gathered.
Federated Learning (FL) [9, 10, 11] is a learning
paradigm that seeks to address the problem of data gover-
nance and privacy by training algorithms collaboratively
without exchanging the underlying datasets. The ap-
proach was originally developed in a different domain,
but it recently gained traction for healthcare applications
because it neatly addresses the problems that usually ex-
ist when trying to aggregate medical data. Applied to
digital health this means that FL enables insights to be
gained collaboratively across institutions, e.g. in the form
of a global or consensus model, without sharing the pa-
tient data. In particular, the strength of FL is that sen-
sitive training data does not need to be moved beyond
the firewalls of the institutions in which they reside. In-
stead, the Machine Learning (ML) process occurs locally
at each participating institution and only model charac-
teristics (e.g. parameters, gradients etc.) are exchanged.
Once training has been completed, the trained consensus
model benefits from the knowledge accumulated across
all institutions. Recent research has shown that this ap-
proach can achieve a performance that is comparable to
a scenario where the data was co-located in a data lake
and superior to the models that only see isolated single-
institutional data [12, 13].
For this reason, we believe that a successful imple-
mentation of FL holds significant potential for enabling
precision medicine at large scale. The scalability with
respect to patient numbers included for model training
would facilitate models that yield unbiased decisions,
optimally reflect an individual’s physiology, and are
sensitive to rare diseases in a way that is respectful of
governance and privacy concerns. Whilst FL still re-
quires rigorous technical consideration to ensure that the
algorithm is proceeding optimally without compromising
safety or patient privacy, it does have the potential to
overcome the limitations of current approaches that
require a single pool of centralised data.
The aim of this paper is to provide context and detail
for the community regarding the benefits and impact of
FL for medical applications (Section 2) as well as high-
lighting key considerations and challenges of implement-
ing FL in the context of digital health (Section 3). The
medical FL use-case is inherently different from other do-
mains, e.g. in terms of number of participants and data di-
versity, and while recent surveys investigate the research
advances and open questions of FL [14, 11, 15], we fo-
cus on what it actually means for digital health and what
is needed to enable it. We envision a federated future for
digital health and hope to inspire and raise awareness with
this article for the community.
2 Data-driven Medicine Requires
Federated Efforts
ML and especially DL is becoming the de facto knowl-
edge discovery approach in many industries, but success-
fully implementing data-driven applications requires that
models are trained and evaluated on sufficiently large and
diverse datasets. These medical datasets are difficult to
curate (Section 2.1). FL offers a way to counteract this
data dilemma and its associated governance and privacy
concerns by enabling collaborative learning without cen-
tralising the data (Section 2.2). This learning paradigm,
however, requires consideration from and offers benefits
to the various stakeholders of the healthcare environment
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Figure 1: Federated Learning Communication Architectures - (a) Client-Server architecture via Hub and Spokes:
A Parameter Server distributes the model and each node trains a local model for several iterations, after which the
updated models are returned to the Parameter Server for aggregation. This consensus model is then redistributed
for subsequent iterations. (b) Decentralised Architecture via peer-to-peer: Rather than using a Parameter Server, each
node broadcasts its locally trained model to some or all of its peers and each node does its own aggregation. (c) Hybrid
Architecture: Federations can be composed into a hierarchy of hubs and spokes, which might represent regions, health
authorities or countries.
(Section 2.3). All these points will be discussed in this
section.
2.1 The Reliance on Data
Data-driven approaches rely on datasets that truly repre-
sent the underlying data distribution of the problem to be
solved. Whilst the importance of comprehensive and en-
compassing databases is a well-known requirement to en-
sure generalisability, state-of-the-art algorithms are usu-
ally evaluated on carefully curated datasets, often orig-
inating from a small number of sources - if not a sin-
gle source. This implies major challenges: pockets of
isolated data can introduce sample bias in which demo-
graphic (e.g. gender, age etc.) or technical imbalances
(e.g. acquisition protocol, equipment manufacturer) skew
the predictions, adversely affecting the accuracy of pre-
diction for certain groups or sites.
The need for sufficiently large databases for AI train-
ing has spawned many initiatives seeking to pool data
from multiple institutions. Large initiatives have so far
primarily focused on the idea of creating data lakes.
These data lakes have been built with the aim of lever-
aging either the commercial value of the data, as exem-
plified by IBM’s Merge Healthcare acquisition [16], or as
a resource for economic growth and scientific progress,
with examples such as NHS Scotland’s National Safe
Haven [17], the French Health Data Hub [18] and Health
Data Research UK [19]. Substantial, albeit smaller, ini-
tiatives have also made data available to the general
community such as The Human Connectome [20], UK
Biobank [21], The Cancer Imaging Archive (TCIA) [22],
NIH CXR8 [23], NIH DeepLesion [24], The Cancer
Genome Atlas (TCGA) [25], the Alzheimer’s disease neu-
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roimaging initiative (ADNI) [26], or as part of medi-
cal grand challenges1 such as the CAMELYON chal-
lenge [27], the multimodal brain tumor image segmenta-
tion benchmark (BRATS) [28] or the Medical Segmen-
tation Decathlon [29]. Public data is usually task- or
disease-specific and often released with varying degrees
of license restrictions, sometimes limiting its exploitation.
Regardless of the approach, the availability of such data
has the potential to catalyse scientific advances, stimulate
technology start-ups and deliver improvements in health-
care.
Centralising or releasing data, however, poses not only
regulatory and legal challenges related to ethics, pri-
vacy and data protection, but also technical ones - safely
anonymising, controlling access, and transferring health-
care data is a non-trivial, and often impossible, task. As
an example, anonymised data from the electronic health
record can appear innocuous and GDPR/PHI compliant,
but just a few data elements may allow for patient rei-
dentification [6]. The same applies to genomic data and
medical images, with their high-dimensional nature mak-
ing them as unique as one’s fingerprint [7]. Therefore,
unless the anonymisation process destroys the fidelity of
the data, likely rendering it useless, patient reidentifica-
tion or information leakage cannot be ruled out. Gated
access, in which only approved users may access specific
subsets of data, is often proposed as a putative solution
to this issue. However, not only does this severely limit
data availability, it is only practical for cases in which the
consent granted by the data owners or patients is uncondi-
tional, since recalling data from those who may have had
access to the data is practically unenforceable.
2.2 The Promise of Federated Efforts
The promise of FL is simple - to address privacy and gov-
ernance challenges by allowing algorithms to learn from
non co-located data. In a FL setting, each data controller
not only defines their own governance processes and as-
sociated privacy considerations, but also, by not allowing
data to move or to be copied, controls data access and
the possibility to revoke it. So the potential of FL is to
provide controlled, indirect access to large and compre-
hensive datasets needed for the development of ML algo-
1https://grand-challenge.org/
rithms, whilst respecting patient privacy and data gover-
nance. It should be noted that this includes both the train-
ing as well as the validation phase of the development. In
this way, FL could create new opportunities, e.g. by al-
lowing large-scale validation across the globe directly in
the institutions, and enable novel research on, for exam-
ple, rare diseases, where the incident rates are low and it is
unlikely that a single institution has a dataset that is suffi-
cient for ML approaches. Moving the to-be-trained model
to the data instead of collecting the data in a central loca-
tion has another major advantage: the high-dimensional,
storage-intense medical data does not have to be dupli-
cated from local institutions in a centralised pool and du-
plicated again by every user that uses this data for local
model training. In a FL setup, only the model is trans-
ferred to the local institutions and can scale naturally with
a potentially growing global dataset without replicating
the data or multiplying the data storage requirements.
Some of the promises of FL are implicit: a certain
degree of privacy is provided since other FL partici-
pants never directly access the data from other institu-
tions and only receive the resulting model parameters that
are aggregated over several participants. And in a Client-
Server Architecture (see Figure 1), in which a federated
server manages the aggregation and distribution, the par-
ticipating institutions can even remain unknown to each
other. However, it has been shown that the models them-
selves can, under certain conditions, memorise informa-
tion [30, 31, 32, 33]. Therefore the FL setup can be fur-
ther enhanced by privacy protections using mechanisms
such as differential privacy [34, 35] or learning from en-
crypted data (c.f. Sec. 3). And FL techniques are still a
very active area of research [14].
All in all, a successful implementation of FL will rep-
resent a paradigm shift from centralised data warehouses
or lakes, with a significant impact on the various stake-
holders in the healthcare domain.
2.3 Impact on Stakeholders
If FL is indeed the answer to the challenge of healthcare
ML at scale, then it is important to understand who the
various stakeholders are in a FL ecosystem and what they
have to consider in order to benefit from it.
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Figure 2: Compute Plan a) Federated Training: Standard approach to federation in which each of the nodes train
in parallel and submit their model updates for aggregation every few epochs. The aggregation may happen on one
of the training nodes or a separate Parameter Server node, which would then redistribute the consensus model. b)
Peer to Peer Training: Nodes broadcast their model updates to one or more nodes in the federation and each does its
own aggregation. Cyclic Training happens when model updates are passed to a single neighbour one or more times,
round-robin style. c) Hybrid Training: Federations, perhaps in remote geographies, can be composed into a hierarchy
and use different communication/aggregation strategies at each tier. In the illustrated case, three federations of varying
size periodically share their models using a peer to peer approach. The consensus model is then redistributed to each
federation and each node therein.
Clinicians are usually exposed to only a certain sub-
group of the population based on the location and demo-
graphic environment of the hospital or practice they are
working in. Therefore, their decisions might be based on
biased assumptions about the probability of certain dis-
eases or their interconnection. By using ML-based sys-
tems, e.g. as a second reader, they can augment their own
expertise with expert knowledge from other institutions,
ensuring a consistency of diagnosis not attainable today.
Whilst this promise is generally true for any ML-based
system, systems trained in a federated fashion are poten-
tially able to yield even less biased decisions and higher
sensitivity to rare cases as they are likely to have seen a
more complete picture of the data distribution. In order
to be an active part of or to benefit from the federation,
however, demands some up-front effort such as compli-
ance with agreements e.g. regarding the data structure,
annotation and report protocol, which is necessary to en-
sure that the information is presented to collaborators in a
commonly understood format.
Patients are usually relying on local hospitals and prac-
tices. Establishing FL on a global scale could ensure
higher quality of clinical decisions regardless of the lo-
cation of the deployed system. For example, patients who
need medical attention in remote areas could benefit from
the same high-quality ML-aided diagnosis that are avail-
able in hospitals with a large number of cases. The same
advantage applies to patients suffering from rare, or geo-
graphically uncommon, diseases, who are likely to have
better outcomes if faster and more accurate diagnoses can
be made. FL may also lower the hurdle for becoming a
data donor, since patients can be reassured that the data re-
mains with the institution and data access can be revoked.
Hospitals and Practices can remain in full control and
possession of their patient data with complete traceability
of how the data is accessed. They can precisely control the
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purpose for which a given data sample is going to be used,
limiting the risk of misuse when they work with third par-
ties. However, participating in federated efforts will re-
quire investment in on-premise computing infrastructure
or private-cloud service provision. The amount of neces-
sary compute capabilities depends of course on whether a
site is only participating in evaluation and testing efforts
or also in training efforts. Even relatively small institu-
tions can participate, since enough of them will gener-
ate a valuable corpus and they will still benefit from col-
lective models generated. One of the drawbacks is that
FL strongly relies on the standardisation and homogeni-
sation of the data formats so that predictive models can
be trained and evaluated seamlessly. This involves signif-
icant standardisation efforts from data managers.
Researchers and AI Developers who want to develop
and evaluate novel algorithms stand to benefit from access
to a potentially vast collection of real-world data. This
will especially impact smaller research labs and start-ups,
who would be able to directly develop their applications
on healthcare data without the need to curate their own
datasets. By introducing federated efforts, precious re-
sources can be directed towards solving clinical needs and
associated technical problems rather than relying on the
limited supply of open datasets. At the same time, it will
be necessary to conduct research on algorithmic strate-
gies for federated training, e.g. how to combine mod-
els or updates efficiently, how to be robust to distribu-
tion shifts, etc., as highlighted in the technical survey pa-
pers [14, 11, 15]. And a FL-based development implies
that the researcher or AI developer cannot investigate or
visualise all of the data on which the model is trained. It
is for example not possible to look at an individual fail-
ure case to understand why the current model performs
poorly on it.
Healthcare Providers in many countries are affected
by the ongoing paradigm shift from volume-based,
i.e. fee-for-service-based, to value-based healthcare. A
value-based reimbursement structure is in turn strongly
connected to the successful establishment of precision
medicine. This is not about promoting more expen-
sive individualised therapies but instead about achieving
better outcomes sooner through more focused treatment,
thereby reducing the costs for providers. By way of ex-
ample, with sufficient data, ML approaches can learn to
recognise cancer-subtypes or genotypic traits from radiol-
ogy images that could indicate certain therapies and dis-
count others. So, by providing exposure to large amounts
of data, FL has the potential to increase the accuracy and
robustness of healthcare AI, whilst reducing costs and im-
proving patient outcomes, and is therefore vital to preci-
sion medicine.
Manufacturers of healthcare software and hardware
could benefit from federated efforts and infrastructures
for FL as well, since combining the learning from
many devices and applications, without revealing any-
thing patient-specific can facilitate the continuous im-
provement of ML-based systems. This potentially opens
up a new source of data and revenue to manufacturers.
However, hospitals may require significant upgrades to
local compute, data storage, networking capabilities and
associated software to enable such a use-case. Note, how-
ever, that this change could be quite disruptive: FL could
eventually impact the business models of providers, prac-
tices, hospitals and manufacturers affecting patient data
ownership; and the regulatory frameworks surrounding
continual and FL approaches are still under development.
3 Technical Considerations
FL is perhaps best-known from the work of Konecˇny`
et al. [36], but various other definitions have been pro-
posed in literature [14, 11, 15, 9]. These approaches can
be realised via different communication architectures (see
Figure 1) and respective compute plans (see Figure 2).
The main goal of FL, however, remains the same: to
combine knowledge learned from non co-located data,
that resides within the participating entities, into a global
model. Whereas the initial application field mostly com-
prised mobile devices, participating entities in the case of
healthcare could be institutions storing the data, e.g. hos-
pitals, or medical devices itself, e.g. a CT scanner or even
low-powered devices that are able to run computations
locally. It is important to understand that this domain-
shift to the medical field implies different conditions and
requirements. For example, in the case of the federated
mobile device application, potentially millions of partici-
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pants could contribute, but it would be impossible to have
the same scale of consortium in terms of participating hos-
pitals. On the other hand medical institutions may rely
on more sophisticated and powerful compute infrastruc-
ture with stable connectivity. Another aspect is that the
variation in terms of data type and defined tasks as well
as acquisition protocol and standardisation in healthcare
is significantly higher than pictures and messages seen in
other domains. The participating entities have to agree on
a collaboration protocol and the high-dimensional med-
ical data, which is predominant in the field of digital
health, poses challenges by requiring models with huge
numbers of parameters. This may become an issue in sce-
narios where the available bandwidth for communication
between participants is limited, since the model has to
be transferred frequently. And even though data is never
shared during FL, considerations about the security of the
connections between sites as well as mitigation of data
leakage risks through model parameters are necessary. In
this section, we will discuss more in detail what FL is and
how it differs from similar techniques as well as highlight-
ing the key challenges and technical considerations that
arise when applying FL in digital health.
3.1 Federated Learning Definition
FL is a learning paradigm in which multiple parties train
collaboratively without the need to exchange or centralise
datasets. Although various training strategies have been
implemented to address specific tasks, a general formula-
tion of FL can be formalised as follows: Let L denote a
global loss function obtained via a weighted combination
of K local losses {Lk}Kk=1, computed from private data
Xk residing at the individual involved parties:
min
φ
L(X;φ) with L(X;φ) =
K∑
k=1
wk Lk(Xk;φ),
(1)
where wk > 0 denote the respective weight coefficients.
It is important to note that the data Xk is never shared
among parties and remains private throughout learning.
In practice, each participant typically obtains and re-
fines the global consensus model by running a few rounds
of optimisation on their local data and then shares the up-
dated parameters with its peers, either directly or via a pa-
rameter server. The more rounds of local training are per-
formed without sharing updates or synchronisation, the
less it is guaranteed that the actual procedure is minimis-
ing the equation (1) [9, 14]. The actual process used
for aggregating parameters commonly depends on the FL
network topology, as FL nodes might be segregated into
sub-networks due to geographical or legal constraints (see
Figure 1). Aggregation strategies can rely on a single ag-
gregating node (hub and spokes models), or on multiple
nodes without any centralisation. An example of this is
peer-to-peer FL, where connections exist between all or
a subset of the participants and model updates are shared
only between directly-connected sites [37, 38]. An exam-
ple of centralised FL aggregation with a client-server ar-
chitecture is given in Algorithm 1. Note that aggregation
strategies do not necessarily require information about the
full model update; clients might choose to share only a
subset of the model parameters for the sake of reducing
communication overhead of redundant information, en-
sure better privacy preservation [10] or to produce multi-
task learning algorithms having only part of their param-
eters learned in a federated manner.
A unifying framework enabling various training
schemes may disentangle compute resources (data and
servers) from the compute plan, as depicted in Figure 2.
The latter defines the trajectory of a model across several
partners, to be trained and evaluated on specific datasets.
For more details regarding state-of-the-art of FL tech-
niques, such as aggregation methods, optimisation or
model compression, we refer the reader to the overview
by Kairouz et al. [14].
3.2 Relation to Similar Strategies
FL is rooted in older forms of collaborative learning
where models are shared or compute is distributed [13,
40]. Transfer Learning, for example, is a well-established
approach of model-sharing that makes it possible to tackle
problems with deep neural networks that have millions of
parameters, despite the lack of extensive, local datasets
that are required for training from scratch: a model is
first trained on a large dataset and then further optimised
on the actual target data. The dataset used for the ini-
tial training does not necessarily come from the same do-
main or even the same type of data source as the target
dataset. This type of transfer learning has shown better
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Algorithm 1 Example of a FL algorithm [12] in a client-
server architecture with aggregation via FedAvg [39].
Require: num federated rounds T
1: procedure AGGREGATING
2: Initialise global model: W (0)
3: for t← 1 · · ·T do
4: for client k ← 1 · · ·K do . Run in parallel
5: Send W (t−1) to client k
6: Receive model updates and number of local
training iterations (∆W (t−1)k , Nk) from client’s local train-
ing with Lk(Xk;W (t−1))
7: end for
8: W (t) ←W (t−1) + 1∑
k Nk
∑
k (Nk ·W (t−1)k )
9: end for
10: return W (t)
11: end procedure
performance [41, 42] when compared to strategies where
the model had been trained from scratch on the target
data only, especially when the target dataset is compara-
bly small. It should be noted that similar to a FL setup,
the data is not necessarily co-located in this approach.
For Transfer Learning, however, the models are usually
shared acyclically, e.g. using a pre-trained model to fine-
tune it on another task, without contributing to a collective
knowledge-gain. And, unfortunately, deep learning mod-
els tend to ”forget” [43, 44]. Therefore after a few training
iterations on the target dataset the initial information con-
tained in the model is lost [45]. To adopt this approach
into a form of collaborative learning in a FL setup with
continuous learning from different institutions, the par-
ticipants can share their model with a peer-to-peer archi-
tecture in a ”round-robin” or parallel fashion and train in
turn on their local data. This yields better results when the
goal is to learn from diverse datasets. A client-server ar-
chitecture in this scenario enables learning on multi-party
data at the same time [13], possibly even without forget-
ting [46].
There are also other collaborative learning strate-
gies [47, 48] such as ensembling, a statistical strategy of
combining multiple independently trained models or pre-
dictions into a consensus, or multi-task learning, a strat-
egy to leverage shared representations for related tasks.
These strategies are independent of the concept of FL, and
can be used in combination with it.
The second characteristic of FL - to distribute the com-
pute - has been well studied in recent years [49, 50,
51]. Nowadays, the training of the large-scale models
is often executed on multiple devices and even multi-
ple nodes [51]. In this way, the task can be parallelised
and enables fast training, such as training a neural net-
work on the extensive dataset of the ImageNet project in
1 hour [50] or even in less than 80 seconds [52]. It should
be noted that in these scenarios, the training is realised in
a cluster environment, with centralised data and fast net-
work communication. So, distributing the compute for
training on several nodes is feasible and FL may benefit
from the advances in this area. Compared to these ap-
proaches, however, FL comes with a significant commu-
nication and synchronisation cost. In the FL setup, the
compute resources are not as closely connected as in a
cluster and every exchange may introduce a significant
latency. Therefore, it may not be suitable to synchronise
after every batch, but to continue local training for several
iterations before aggregation.
We refer the reader to the survey by Xu et al. [15] for
an overview of the evolution of Federated Learning and
the different concepts in the broader sense.
3.3 Challenges and Considerations
Despite the advantages of FL, there are challenges that
need to be taken into account when establishing federated
training efforts. In this section, we discuss five key as-
pects of FL that are of particular interest in the context of
its application to digital health.
3.3.1 Privacy and Security
In healthcare, we work with highly sensitive data that
must be protected accordingly. Therefore, some of the key
considerations are the trade-offs, strategies and remaining
risks regarding the privacy-preserving potential of FL.
Privacy Vs. Performance. Although one of the main
purposes of FL is to protect privacy by sharing model up-
dates rather than data, FL does not solve all potential pri-
vacy issues and - similar to ML algorithms in general -
will always carry some risks. Strict regulations and data
governance policies make any leakage, or perceived risk
of leakage, of private information unacceptable. These
regulations may even differ between federations and a
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catch-all solution will likely never exist. Consequently,
it is important that potential adopters of FL are aware of
potential risks and state-of-the-art options for mitigating
them. Privacy-preserving techniques for FL offer levels
of protection that exceed today’s current commercially
available ML models [14]. However, there is a trade-off
in terms of performance and these techniques may affect
for example the accuracy of the final model [10]. Fur-
thermore future techniques and/or ancillary data could be
used to compromise a model previously considered to be
low-risk.
Level of Trust. Broadly speaking, participating parties
can enter two types of FL collaboration:
Trusted - for FL consortia in which all parties are con-
sidered trustworthy and are bound by an enforceable col-
laboration agreement, we can eliminate many of the more
nefarious motivations, such as deliberate attempts to ex-
tract sensitive information or to intentionally corrupt the
model. This reduces the need for sophisticated counter-
measures, falling back to the principles of standard col-
laborative research.
Non-trusted - in FL systems that operate on larger
scales, it is impractical to establish an enforceable collab-
orative agreement that can guarantee that all of the parties
are acting benignly. Some may deliberately try to degrade
performance, bring the system down or extract informa-
tion from other parties. In such an environment, security
strategies will be required to mitigate these risks such as,
encryption of model submissions, secure authentication
of all parties, traceability of actions, differential privacy,
verification systems, execution integrity, model confiden-
tiality and protections against adversarial attacks.
Information leakage. By definition, FL systems
sidestep the need to share healthcare data among partici-
pating institutions. However, the shared information may
still indirectly expose private data used for local train-
ing, for example by model inversion [53] of the model
updates, the gradients themselves [54] or adversarial at-
tacks [55, 56]. FL is different from traditional training in-
sofar as the training process is exposed to multiple parties.
As a result, the risk of leakage via reverse-engineering
increases if adversaries can observe model changes over
time, observe specific model updates (i.e. a single institu-
tion’s update), or manipulate the model (e.g. induce ad-
ditional memorisation by others through gradient-ascent-
style attacks). Countermeasures, such as limiting the
granularity of the shared model updates and to add spe-
cific noise to ensure differential privacy [34, 12, 57] may
be needed and is still an active area of research [14].
3.3.2 Data heterogeneity
Medical data is particularly diverse - not only in terms of
type, dimensionality and characteristics of medical data
in general but also within a defined medical task, due to
factors like acquisition protocol, brand of the medical de-
vice or local demographics. This poses a challenge for FL
algorithms and strategies: one of the core assumptions of
many current approaches is that the data is independent
and identically distributed (IID) across the participants.
Initial results indicate that FL training on medical non-
IID data is possible, even if the data is not uniformly dis-
tributed across the institutions [12, 13]. In general how-
ever, strategies such as FedAvg [9] are prone to fail under
these conditions [58, 59, 60], in part defeating the very
purpose of collaborative learning strategies. Research ad-
dressing this problem includes for example FedProx [58]
and part-data-sharing strategy [60]. Another challenge is
that data heterogeneity may lead to a situation in which
the global solution may not be the optimal final local so-
lution. The definition of model training optimality should
therefore be agreed by all participants before training.
3.3.3 Traceability and accountability
As per all safety-critical applications, the reproducibility
of a system is important for FL in healthcare. In contrast
to training on centralised data, FL involves running multi-
party computations in environments that exhibit complex-
ities in terms of hardware, software and networks. The
traceability requirement should be fulfilled to ensure that
system events, data access history and training config-
uration changes, such as hyperparameter tuning, can be
traced during the training processes. Traceability can also
be used to log the training history of a model and, in par-
ticular, to avoid the training dataset overlapping with the
test dataset. In particular in non-trusted federations, trace-
ability and accountability processes running in require ex-
ecution integrity. After the training process reaches the
mutually agreed model optimality criteria, it may also be
helpful to measure the amount of contribution from each
participant, such as computational resources consumed,
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quality of the local training data used for local training etc.
The measurements could then be used to determine rele-
vant compensation and establish a revenue model among
the participants [61].
One implication of FL is that researchers are not able to
investigate images upon which models are being trained.
So, although each site will have access to its own raw
data, federations may decide to provide some sort of se-
cure intra-node viewing facility to cater for this need or
perhaps even some utility for explainability and inter-
pretability of the global model. However, the issue of in-
terpretability within DL is still an open research question.
3.3.4 System architecture
Unlike running large-scale FL amongst consumer devices,
healthcare institutional participants are often equipped
with better computational resources and reliable and
higher throughput networks. These enable for example
training of larger models with larger numbers of local
training steps and sharing more model information be-
tween nodes. This unique characteristic of FL in health-
care consequently brings opportunities as well as chal-
lenges such as (1) how to ensure data integrity when com-
municating (e.g. creating redundant nodes); (2) how to
design secure encryption methods to take advantage of the
computational resources; (3) how to design appropriate
node schedulers and make use of the distributed compu-
tational devices to reduce idle time.
The administration of such a federation can be realised
in different ways, each of which come with advantages
and disadvantages. In high-trust situations, training may
operate via some sort of ’honest broker’ system, in which
a trusted third party acts as the intermediary and facili-
tates access to data. This setup requires an independent
entity to control the overall system which may not always
be desirable, since it could involve an additional cost and
procedural viscosity, but does have the advantage that the
precise internal mechanisms can be abstracted away from
the clients, making the system more agile and simpler to
update. In a peer-to-peer system each site interacts di-
rectly with some or all of the other participants. In other
words, there is no gatekeeper function, all protocols must
be agreed up-front, which requires significant agreement
efforts, and changes must be made in a synchronised fash-
ion by all parties to avoid problems. And in a trustless-
based architecture the platform operator may be crypto-
graphically locked into being honest which creates signif-
icant computation overheads whilst securing the protocol.
3.3.5 Initiatives and consortia
Future efforts to apply artificial intelligence to healthcare
tasks may strongly depend on collaborative strategies be-
tween multiple institutions rather than large centralised
databases belonging to only one hospital or research labo-
ratory. The ability to leverage FL to capture and integrate
knowledge acquired and maintained by different institu-
tions provides an opportunity to capture larger data vari-
ability and analyse patients across different demograph-
ics. Moreover, FL is an opportunity to incorporate multi-
expert annotation and multi-centre data acquired with dif-
ferent instruments and techniques. This collaborative ef-
fort requires, however, various agreements including def-
initions of scope, aim and technology which, since it is
still novel, may incorporate several unknowns. In this
context, large-scale initiatives such as the MELLODDY
project 2, the HealthChain project 3, the Trustworthy Fed-
erated Data Analytics (TFDA) and the German Cancer
Consortium’s Joint Imaging Platform (JIP) 4 represent pi-
oneering efforts to set the standards for safe, fair and in-
novative collaboration in healthcare research.
4 Conclusion
ML, and particularly DL, has led to a wide range of inno-
vations in the area of digital healthcare. As all ML meth-
ods benefit greatly from the ability to access data that ap-
proximates the true global distribution, FL is a promising
approach to obtain powerful, accurate, safe, robust and
unbiased models. By enabling multiple parties to train
collaboratively without the need to exchange or centralise
datasets, FL neatly addresses issues related to egress of
sensitive medical data. As a consequence, it may open
novel research and business avenues and has the potential
to improve patient care globally. In this article, we have
discussed the benefits and the considerations pertinent to
2http://www.imi.europa.eu/projects-results/project-
factsheets/melloddy
3https://www.substra.ai/en/healthchain-project
4https://www.dkfz.de/en/datascience/platforms-initiatives.html
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FL within the healthcare field. Not all technical questions
have been answered yet and FL will certainly be an active
research area throughout the next decade [14]. Despite
this, we truly believe that its potential impact on precision
medicine and ultimately improving medical care is very
promising.
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